Pacira Pharmaceuticals buy HC Wainwright
Start price
17.11.25
/
50%
€20.80
Target price
17.11.26
€32.74
Performance (%)
-12.02%
Price
16.01.26
€17.70
Summary
This prediction is currently active. The prediction for Pacira Pharmaceuticals disappoints with a performance of -12.02%. This prediction currently runs until 17.11.26. The prediction end date can be changed by HC_Wainwright at any time. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacira Pharmaceuticals | -13.235% | -13.235% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by HC_Wainwright for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences (NASDAQ:PCRX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
Stopped prediction by HC_Wainwright for Pacira Pharmaceuticals
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€24.00
08.04.25
08.04.25
€59.31
08.04.26
08.04.26
-30.83%
16.01.26
16.01.26
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€24.20
28.02.25
28.02.25
€67.25
28.02.26
28.02.26
-31.41%
16.01.26
16.01.26
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€16.20
04.12.24
04.12.24
€37.19
04.12.25
04.12.25
24.69%
05.12.25
05.12.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€21.20
02.07.24
02.07.24
€53.05
02.07.25
02.07.25
-8.96%
03.07.25
03.07.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.80
08.05.24
08.05.24
€53.04
08.05.25
08.05.25
-25.75%
09.05.25
09.05.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€26.20
04.03.24
04.03.24
€52.53
04.03.25
04.03.25
-15.27%
05.03.25
05.03.25
Pacira Pharmaceuticals
Start price
Target price
Perf. (%)
€28.40
06.11.23
06.11.23
€53.07
06.11.24
06.11.24
-42.96%
07.11.24
07.11.24